INVO Fertility, Inc. (IVF NASDAQ) stock market data APIs
$0.9717
0(0%)
as of September 11, 2026
Try our APIs with
free plan!
INVO Fertility, Inc. Financial Data Overview
Price chart is built with
Anychart
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.
Prev. Close
0.9717
Open
0.9762
High
0.9807
Low
0.963
52 wk Range
0.9-56
Market Cap
2 430 K
P/E Ratio
0.0027
Shares Outstanding
2 507 K
Revenue
7 531 K
EPS
0.35
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get INVO Fertility, Inc. data using free add-ons & libraries
Get INVO Fertility, Inc. Fundamental Data
INVO Fertility, Inc. Fundamental data includes:
- Net Revenue: 7 531 K
- EBITDA: -5 366 924
- Earnings Per Share: 359
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-14
- EPS/Forecast: -5.6
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
INVO Fertility, Inc. News
New
INVO BioScience GAAP EPS of $0.35 beats by $5.55, revenue of $2.18M misses by $0.53M
* INVO BioScience press release [https://seekingalpha.com/pr/20620899-invo-fertility-reports-second-quarter-2026-results-highlighting-revenue-growth-and-clinic] (IVF [https://seekingalpha.com/symbol...
INVO Fertility Q2 Revenue Rises 17% as Clinic-Level Profitability Improves
Financial report ©Shutterstock INVO Fertility (NASDAQ:IVF) reported a 17% increase in second-quarter 2026 revenue to $2.18 million as the first full-quarter contribution from Family Beginnings and g...
INVO Records Q1 Net Loss Of $5 Mln; Stock Down
(RTTNews) - INVO Fertility Inc. (IVF), a healthcare fertility company, on Monday reported financial results for the first quarter ending on March 31, 2026, recording a net loss of $5.5 million. Share...
Pre-Market Movers: PMI, CNTB, RNAZ Chart The Course
(RTTNews) - Pre-market trading is offering an early glimpse into biotech stocks likely to attract investor attention this Wednesday. Significant price moves ahead of the opening bell are being driven...
Get INVO Fertility, Inc. fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
